Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Case-control Study to Evaluate the Vaccine Effectiveness of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Human Rotavirus (HRV) Vaccine (Rotarix™) Against Community-acquired Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children Born After 1 October 2006, in Belgium

NCT01177826 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01177826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01177826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Case-control Study to Evaluate the Vaccine Effectiveness of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Human Rotavirus (HRV) Vaccine (Rotarix™) Against Community-acquired Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children Born After 1 October 2006, in Belgium
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
February 23, 2008
Completion date
June 11, 2010
Enrollment
643 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

infections, rotavirus, rotavirus vaccines